223 related articles for article (PubMed ID: 20429954)
1. Age groups and spread of influenza: implications for vaccination strategy.
Hsieh YH
BMC Infect Dis; 2010 Apr; 10():106. PubMed ID: 20429954
[TBL] [Abstract][Full Text] [Related]
2. Modeling optimal age-specific vaccination strategies against pandemic influenza.
Lee S; Golinski M; Chowell G
Bull Math Biol; 2012 Apr; 74(4):958-80. PubMed ID: 22147102
[TBL] [Abstract][Full Text] [Related]
3. Planning for the next influenza H1N1 season: a modelling study.
Carrat F; Pelat C; Levy-Bruhl D; Bonmarin I; Lapidus N
BMC Infect Dis; 2010 Oct; 10():301. PubMed ID: 20964814
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
Lugnér AK; van Boven M; de Vries R; Postma MJ; Wallinga J
BMJ; 2012 Jul; 345():e4445. PubMed ID: 22791791
[TBL] [Abstract][Full Text] [Related]
5. Parameterizing a dynamic influenza model using longitudinal versus age-stratified case notifications yields different predictions of vaccine impacts.
A Andrews M; T Bauch C
Math Biosci Eng; 2019 Apr; 16(5):3753-3770. PubMed ID: 31499635
[TBL] [Abstract][Full Text] [Related]
6. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales.
Pitman RJ; White LJ; Sculpher M
Vaccine; 2012 Feb; 30(6):1208-24. PubMed ID: 22178725
[TBL] [Abstract][Full Text] [Related]
7. Optimal H1N1 vaccination strategies based on self-interest versus group interest.
Shim E; Meyers LA; Galvani AP
BMC Public Health; 2011 Feb; 11 Suppl 1(Suppl 1):S4. PubMed ID: 21356133
[TBL] [Abstract][Full Text] [Related]
8. Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.
Dodd CN; de Ridder M; Huang WT; Weibel D; Giner-Soriano M; Perez-Vilar S; Diez-Domingo J; Svenson LW; Mahmud SM; Carleton B; Naus M; Kwong JC; Murray BJ; Arnheim-Dahlstrom L; Pedersen L; Morros R; Puertas FJ; Black S; Sturkenboom M
PLoS One; 2018; 13(10):e0204799. PubMed ID: 30332477
[TBL] [Abstract][Full Text] [Related]
9. Serological evidence of subclinical transmission of the 2009 pandemic H1N1 influenza virus outside of Mexico.
Chao DY; Cheng KF; Li TC; Wu TN; Chen CY; Tsai CA; Chen JH; Chiu HT; Lu JJ; Su MC; Liao YH; Chan WC; Hsieh YH
PLoS One; 2011 Jan; 6(1):e14555. PubMed ID: 21267441
[TBL] [Abstract][Full Text] [Related]
10. Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything.
Conway JM; Tuite AR; Fisman DN; Hupert N; Meza R; Davoudi B; English K; van den Driessche P; Brauer F; Ma J; Meyers LA; Smieja M; Greer A; Skowronski DM; Buckeridge DL; Kwong JC; Wu J; Moghadas SM; Coombs D; Brunham RC; Pourbohloul B
BMC Public Health; 2011 Dec; 11():932. PubMed ID: 22168242
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic parameters and evaluation of control measure for 2009 novel influenza a (H1N1) in Xiamen, Fujian Province, China.
Shen J; Niu J
Virol J; 2012 Jan; 9():20. PubMed ID: 22248240
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan.
Chen CJ; Lee PI; Chang SC; Huang YC; Chiu CH; Hsieh YC; Chang SC; Chang FY; Lee JJ; Su SC; Shen GH; Chuang YC; Chen YS; Liu JW; Lin TY
PLoS One; 2011; 6(9):e24440. PubMed ID: 21909433
[TBL] [Abstract][Full Text] [Related]
13. Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway--and the influence of vaccination timing.
Blasio BF; Iversen BG; Tomba GS
PLoS One; 2012; 7(1):e30018. PubMed ID: 22253862
[TBL] [Abstract][Full Text] [Related]
14. Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9.
Mathews JD; McBryde ES; McVernon J; Pallaghy PK; McCaw JM
BMC Infect Dis; 2010 May; 10():128. PubMed ID: 20497585
[TBL] [Abstract][Full Text] [Related]
15. On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic.
Hsieh YH; Huang HM; Lan YC
PLoS One; 2016; 11(5):e0154695. PubMed ID: 27139905
[TBL] [Abstract][Full Text] [Related]
16. Optimal strategies of social distancing and vaccination against seasonal influenza.
Shim E
Math Biosci Eng; 2013; 10(5-6):1615-34. PubMed ID: 24245639
[TBL] [Abstract][Full Text] [Related]
17. Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009.
Jackson ML; France AM; Hancock K; Lu X; Veguilla V; Sun H; Liu F; Hadler J; Harcourt BH; Esposito DH; Zimmerman CM; Katz JM; Fry AM; Schrag SJ
Clin Infect Dis; 2011 Sep; 53(5):455-62. PubMed ID: 21844028
[TBL] [Abstract][Full Text] [Related]
18. Spatial and temporal characteristics of the 2009 A/H1N1 influenza pandemic in Peru.
Chowell G; Viboud C; Munayco CV; Gómez J; Simonsen L; Miller MA; Tamerius J; Fiestas V; Halsey ES; Laguna-Torres VA
PLoS One; 2011; 6(6):e21287. PubMed ID: 21712984
[TBL] [Abstract][Full Text] [Related]
19. Revealing the True Incidence of Pandemic A(H1N1)pdm09 Influenza in Finland during the First Two Seasons - An Analysis Based on a Dynamic Transmission Model.
Shubin M; Lebedev A; Lyytikäinen O; Auranen K
PLoS Comput Biol; 2016 Mar; 12(3):e1004803. PubMed ID: 27010206
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.
Baguelin M; Hoek AJ; Jit M; Flasche S; White PJ; Edmunds WJ
Vaccine; 2010 Mar; 28(12):2370-84. PubMed ID: 20096762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
